OrphoMed, Inc. — Form D
OrphoMed, Inc. of MILL VALLEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-24. The offering totals $39.3M, of which $21.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-05-24
- Form: D
- Accession: 0001140361-17-022087
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $39.3M
- Amount sold: $21.8M
- Remaining: $17.5M
- Investors: 17
- Date of first sale: 2017-05-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287373
Issuer
- Name: OrphoMed, Inc.
- CIK: 0001650809
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 806 DENISE COURT, MILL VALLEY, CA, 94941
- Phone: (949) 275-4478
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| MICHAEL MARTIN | Director | Minneapolis, MN |
| Art Pappas | Director | Cambridge, MA |
| Nikhilesh Singh | Director | Mill Valley, CA |
| Frank Torti | Director | New York, NY |
| Kenneth Widder | Director | Mill Valley, CA |
| Nikhilesh Singh | Executive Officer | Mill Valley, CA |
| Michael D Chao | Director | Mill Valley, CA |
| Nikhilesh Singh, Ph.D. | Director | Mill Valley, CA |
| Nikhilesh Singh, Ph.D. | Executive Officer | Mill Valley, CA |
| Thomas D Kiley | Director | San Francisco, CA |
Other filings by this issuer (2)
More